Adherence to oral HIV pre-exposure prophylaxis among female sex workers in Kampala, Uganda

被引:7
作者
Nalukwago, Grace Kakoola [1 ,2 ]
Isunju, John Bosco [1 ]
Muwonge, Timothy [2 ]
Katairo, Thomas [3 ]
Bunani, Nelson [4 ]
Semitala, Fred [3 ]
Kyambadde, Peter [4 ]
Matovu, Flavia [5 ,6 ]
机构
[1] Makerere Univ, Publ Hlth, Coll Hlth Sci, Kampala, Uganda
[2] Makerere Univ, Infect Dis Inst, Res, Kampala, Uganda
[3] Makerere Univ, Coll Hlth Sci, Sch Med, Clin Epidemiol Unit, Kampala, Uganda
[4] Most Risk Populat Iniat MarPI, Kampala, Uganda
[5] Makerere Univ, Sch Publ Hlth Epidemiol & Biostat, Kampala, Uganda
[6] MU JHU Res Collaborat, Kampala, Uganda
基金
美国国家卫生研究院;
关键词
Oral PrEP; adherence; female sex workers; PREVENTION; MEN;
D O I
10.4314/ahs.v21i3.12
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: In Kampala Uganda, female sex workers (FSWs) have high HIV prevalence (33%). Oral PrEP is a novel HIV prevention intervention that offers hope to decrease HIV incidence in key populations especially among FSWs. Studies have shown that with poor adherence, oral PrEP has no efficacy, and therefore adherence to PrEP is critical among FSWs to maximize HIV prevention. However, implementation data on adherence to PrEP among FSWs is limited so this study sought to assess adherence to PrEP. Specifically, we sought to 1) determine the level of adherence to PrEP among FSWs, and 2) determine factors associated with PrEP adherence. Methods: This cross-sectional study was conducted from November to December 2018; 126 FSWs using PrEP were interviewed using a questionnaire. Adherence was categorically defined as high adherence and low adherence. Logistic regression was done. Results: Using long-term contraception methods (OR 0.06, 95% CI: 0.04-0.77) and not using condoms with clients (OR 0.07, 95% CI: 0.01-0.42) were negatively associated with high PrEP adherence. Conclusion: Barriers to PrEP adherence need to be addressed for successful PrEP implementation to improve adherence going forward. Service care providers should reinforce positive behaviors such as use of condoms devotedly during PrEP breaks.
引用
收藏
页码:1048 / 1058
页数:11
相关论文
共 30 条
[1]  
Andersen R., 2005, MILBANK Q, V83, DOI [10.1111/j.1468-0009.2005.00428.x, DOI 10.1111/J.1468-0009.2005.00428.X]
[2]   Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men [J].
Anderson, Peter L. ;
Glidden, David V. ;
Liu, Albert ;
Buchbinder, Susan ;
Lama, Javier R. ;
Vicente Guanira, Juan ;
McMahan, Vanessa ;
Bushman, Lane R. ;
Casapia, Martin ;
Montoya-Herrera, Orlando ;
Veloso, Valdilea G. ;
Mayer, Kenneth H. ;
Chariyalertsak, Suwat ;
Schechter, Mauro ;
Bekker, Linda-Gail ;
Kallas, Esper Georges ;
Grant, Robert M. .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (151)
[3]  
[Anonymous], 1999, Money and Banking Statistics: Handbook for the compilation of flow statistics
[4]  
[Anonymous], 2006, 17 FACT SHEETS CONCI
[5]  
[Anonymous], 2018, Consolidated Guidelines for Prevention and Treatment of HIV in Uganda
[6]   Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIV [J].
Auerbach, Judith D. ;
Kinsky, Suzanne ;
Brown, Gina ;
Charles, Vignetta .
AIDS PATIENT CARE AND STDS, 2015, 29 (02) :102-110
[7]  
Baeten J, 2015, C RETR OPP INF SEATT
[8]   Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women [J].
Baeten, J. M. ;
Donnell, D. ;
Ndase, P. ;
Mugo, N. R. ;
Campbell, J. D. ;
Wangisi, J. ;
Tappero, J. W. ;
Bukusi, E. A. ;
Cohen, C. R. ;
Katabira, E. ;
Ronald, A. ;
Tumwesigye, E. ;
Were, E. ;
Fife, K. H. ;
Kiarie, J. ;
Farquhar, C. ;
John-Stewart, G. ;
Kakia, A. ;
Odoyo, J. ;
Mucunguzi, A. ;
Nakku-Joloba, E. ;
Twesigye, R. ;
Ngure, K. ;
Apaka, C. ;
Tamooh, H. ;
Gabona, F. ;
Mujugira, A. ;
Panteleeff, D. ;
Thomas, K. K. ;
Kidoguchi, L. ;
Krows, M. ;
Revall, J. ;
Morrison, S. ;
Haugen, H. ;
Emmanuel-Ogier, M. ;
Ondrejcek, L. ;
Coombs, R. W. ;
Frenkel, L. ;
Hendrix, C. ;
Bumpus, N. N. ;
Bangsberg, D. ;
Haberer, J. E. ;
Stevens, W. S. ;
Lingappa, J. R. ;
Celum, C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (05) :399-410
[9]   HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial [J].
Baeten, Jared M. ;
Donnell, Deborah ;
Gichangi, Peter B. ;
Heller, Kate B. ;
Hofmeyr, G. Justus ;
Kiarie, James ;
Mastro, Timothy D. ;
Morrison, Charles S. ;
Mugo, Nelly R. ;
Nanda, Kavita ;
Palanee-Phillips, Thesla ;
Pleaner, Melanie ;
Rees, Helen ;
Scoville, Caitlin W. ;
Shears, Kathleen ;
Steyn, Petrus S. ;
Taylor, Douglas ;
Thomas, Katherine K. ;
Welch, Julia D. ;
Justman, Jessica ;
Nhlabatsi, Zelda ;
Bukusi, Elizabeth A. ;
Onono, Maricianah ;
Louw, Cheryl ;
Bekker, Linda-Gail ;
Nair, Gonasagrie ;
Smit, Jennifer ;
Hofmeyr, G. Justus ;
Singata-Madliki, Mandisa ;
Smit, Edendale Jennifer ;
Palanee-Phillips, Thesla ;
Selepe, Raesibe Agnes Pearl ;
Sibiya, Sydney ;
Ahmed, Khatija ;
Kasaro, Margaret Phiri ;
Stringer, Jeffrey .
LANCET, 2019, 394 (10195) :303-313
[10]  
Centers for Disease Control and Prevention (CDC), 2018, PREEXP PROPH PREV HI